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To identify the medications general practitioners consider for the treatment of persistent isolated cough, we 
undertook a postal questionnaire survey of a sample of general practitioners in east London. Fewer than 10% 
indicated that they never prescribed for such cough. About 70% sometimes considered antibiotics and/or 
bronchodilators in all age groups. Inhaled steroids and cromoglycate were considered by about 30% of prescribers 
for infants compared with over 60% for older age groups. As yet there is no evidence that medication is beneficial 
for persistent isolated cough. The role of asthma drugs for children with this symptom needs to be evaluated so that 
we can better identify those who are likely to benefit. 
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Introduction 
Isolated persistent cough is a common symptom in children 
but to date there is no evidence from rigorous clinical trials 
that medication is of value. Of parents answering a 
questionnaire about children’s respiratory symptoms, 9% 
thought their child coughed more than other children (1) 
and many such children are diagnosed as having asthma. 
Recent reports suggest that clinical and epidemiological 
aspects of persistent cough in childhood differ from asthma 
in childhood (2,3). The British Thoracic Society’s guidelines 
state ‘criteria for defining asthma in the presence of chronic 
or recurrent cough have not been adequately defined’ and 
recommend a trial of asthma treatment in children with 
chronic cough (4). Reporting of children’s cough by parents 
is poorly validated by audiotape recording (5,6). Thus, a 
diagnosis of asthma based on parents’ reporting is possibly 
unreliable. Asthma treatment for isolated persistent cough 
with no other evidence of reversible airway disease needs to 
be evaluated. 
The purpose of this study was to identify which drugs 
general practitioners in east London are considering pre- 
scribing for persistent cough. We were particularly inter- 
ested to know what asthma drugs were being considered for 
which age groups. 
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Methods 
A postal questionnaire defined persistent cough. This was 
either cough on more than three occasions in 6 months 
without runny nose or eyes, no fever and no other symp- 
toms, or cough for more than 3 weeks as the only symptom 
or sign. It asked about prescribing of antibiotics, cough 
linctus, bronchodilators, inhaled steroids, cromoglycate, 
other drugs and no medication for age-groups < 1, 1-4, 559 
and lo-14 years. One of three unambiguous responses 
could be selected for each drug in each age-group: ‘always’, 
‘sometimes’ or ‘never’. A reason could be given for the 
choice and there were two open questions, one about other 
approaches to management and the other about clinical 
features which would suggest that a child with persistent 
cough had asthma. 
A total of 120 general practitioners were selected 
randomly from 360 names on the City and East London 
General Practice Database. This number was chosen so 
that with a minimum response rate of 65% the percentages 
of general practitioners prescribing each drug category 
would be identified within * 10% (95% confidence 
limits). 
Analyses were undertaken on SSPS-PC. Findings are 
expressed as percentages with 95% confidence intervals. 
Using x2 testing, comparisons between age-groups for each 
drug were made for each of the response categories 
‘always’, ‘ sometimes’ and ‘never’ and similarly comparisons 
were made between drugs for each age group for each 
response category. Significant differences (PcO.05) are 
reported. 
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Inhaled steroids Bronchodilators Cromoglycate 
FIG. 1. Prescribing considerations for persistent cough (number of respondents, 84; error bars indicate 95% confidence 
<l year; 4, l-4 years; q , 5-9 years; @, lo-14 years. 
Results COMPARISONS BETWEEN DRUG5 
Eighty-four questionnaires were returned representing 
a response rate of 70%. Five more returns were blank. 
Figure 1 shows the choice of medication by age-group but 
excludes the ‘other drugs’ category where the majority 
(65-85% according to age-group) gave no response. 
Depending on the age category, only one to four of the 84 
respondents (I 5%; 0.3-9.7%) replied that they never pre- 
scribed. Only 14-16 (~20%; 9.626.7%) never considered 
prescribing antibiotics. 
COMPARISONS BETWEEN AGE GROUPS 
(FIG. 1) 
Bronchodilators were ‘always’ considered more frequently 
for children over 5 years than for infants (P=O,O3). The 
reply of ‘sometimes’ to cough linctus prescribing was sig- 
nificantly greater for children in the older age groups than 
in infants (PcO.05). The difference was more marked for 
inhaled corticosteroids (P<O.OOl) and cromoglycate 
(PcO.001). The consideration of ‘never’ to treat with cough 
linctus was significantly more frequent for infants than 
for children over 5 years (P<O.OOl). The reply of ‘never’ 
to treat with corticosteroids occurred significantly more 
frequently for infants than for older age bands (P<O.OOl). 
For the infants, more respondents replied that they ‘never’ 
prescribed inhaled steroids, cromoglycate or cough linctus 
than other medications (P<O.O02). In the 14 year age- 
group bronchodilators were ‘never’ considered by fewer 
respondents than any other medication (P<O.Ol). Similarly 
in the two older age-groups the reply of ‘never’ was 
significantly less frequent for treatment with broncho- 
dilators than it was for other forms of medication 
(P<O.O36). 
REASONS FOR CHOICE OF DRUG 
At least one reason for their choice of drug was given by 
63% (54/84) respondents. Parental pressure was the reason 
for 13 respondents prescribing cough linctus and 11 pre- 
scribing antibiotics to infants. Seventeen indicated that they 
prescribed asthma drugs as a trial of therapy. In the l-4 
year age-group; concern about asthma was mentioned by 
32 respondents and by 21 in each of the older groups. 
OTHER APPROACHES TO MANAGEMENT OF 
COUGH 
This open question was replied to by 87% (73/84) with a 
range of answers. The most frequent consideration was 
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investigation for allergy and asthma (30173) and advice 
about possible environmental triggers, including cigarette 
smoke (15173). Other treatments included steam (six), 
humidifier (five), saline nose-drops (four), steroid nose- 
drops (two), oral steroids (two), theophylline (two), iprat- 
ropium, anti-histamine, gargle, honey and homeopathy. 
WHAT MADE RESPONDENTS CONSIDER 
ASTHMA IN PERSISTENT COUGH? 
The most frequent answer to this question was a 
family history of atopic disease (43/73). Exercise-induced 
symptoms or night-time symptoms were mentioned by 
40173. 
Discussion 
We chose to circulate a sample of general practitioners so 
that we could discover within * 10% of the sample for each 
drug category which medications they say they are prescrib- 
ing. This study provides no information about the fre- 
quency or quantities of medications prescribed. There is no 
way of finding out from routinely collected prescribing data 
what is prescribed for a specific condition in specific age 
groups (7) and so we could not have validated information 
about prescribing frequency had we asked about it. We 
designed our questionnaire to obtain information only 
about prescribing considerations. We deliberately chose the 
term ‘sometimes’ recognizing that this could represent a 
prescribing frequency from a minority to a majority of 
occasions. It is also true that family doctors in other 
areas and especially in other countries may have different 
considerations. 
The response rate to the questionnaire was surprisingly 
high (70%). General practitioners can be swamped with 
questionnaires (8) and our success may reflect the brevity 
and design of ours (9). Some fields were not completed. 
Possibly some responders ignored categories where they did 
not prescribe. Non-responding was most frequent for the 
field ‘other’ and this would support this assumption. Most 
replies were for antibiotics and bronchodilators. 
The majority said they prescribed something for 
persistent cough in the absence of other symptoms. It is 
acknowledged that antibiotics are of no value for isolated 
cough (9,lO). If parents expect antibiotics then a diagnosis 
of acute bronchitis may be made and antibiotics prescribed 
(11,12), although this may not be the whole story (13). 
Prescribing ineffective antitussives for cough has been 
restricted but cough linctus may still be a cheap placebo. 
Several of those who gave a reason for prescribing a 
particular drug mentioned parental pressure. Perhaps the 
results of this study could be used as a starting point for 
local audit. 
It has been suggested that asthma is likely in only a 
minority of children with persistent nocturnal cough (14). 
Isolated cough is more likely to be associated with environ- 
mental factors whereas a diagnosis of asthma is more likely 
to be associated with a personal or family history of atopy 
(1). Indeed, the respondents in our study indicated that 
many were giving advice about environmental factors to 
families whose children coughed and considered family 
history in the diagnosis of asthma. However, on present 
evidence there is little to support the diagnosis of asthma in 
most persistent coughers. Certainly asthmatics cough recur- 
rently or chronically but those with cough-variant asthma 
have some evidence of airways obstruction (15). It is rarely 
possible to demonstrate this in pre-school children without 
special lung function testing. Many children and their 
parents may not perceive wheeziness. A trial of broncho- 
dilators seems reasonable in the first instance. In our study, 
18% of our sample of general practitioners said that they 
always prescribed bronchodilators in the two older age- 
groups. Very few said that they never prescribed asthma 
drugs. Several respondents indicated that they would 
investigate for allergy and reversibility of airways obstruc- 
tion. Undoubtedly some children with persistent cough 
have asthma and it is encouraging that this approach is 
being considered. However, controlled studies are needed 
to evaluate the place of asthma drugs for this common 
symptom. How can children who are likely to benefit best 
be identified? Otherwise these drugs could replace anti- 
biotics as prescribed medication for non-specific recurrent 
or chronic respiratory symptoms. Defining the role of 
asthma drugs and targeting inappropriate prescribing of 
other drugs should be a priority for the cost-effective 
management of persistent cough in children. 
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